근위축성 측삭경화증에 대한 한방 치료의 임상선행연구

키워드

참고문헌 (40)

1. Williams DB, "Motor neuron disease(amyotrophic lateral sclerosis)", Mayo Clin Proc, 통권 : 66, pp.54~82 (1991)
2. Caroscio JT, "Amyotrophic lateral sclerosis its natural history", Neurol Clin., 5, pp.1~9 (1987)
3. Kim SH, "Diagnosis and therapeutic strategies of amyotrophic lateral sclerosis", Hanyang medical reviews, 26(1), pp.44~51 (2006)
4. Traynor BJ, "An outcome study of riluzole in amyotrophic lateral sclerosis. A population based study in Ireland, 1996-2000", Journal of Neurology, 250, pp.473~479 (2000)
5. Lacomblez L, "Dose-ranging study of riluzole in amyotrophic lateral sclerosis", Lancet., 347(9013), pp.1425~1431 (1996), Amyotrophic lateral sclerosis[DOI]
6. Brooks BR, "World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis", Amyotroph Lateral Scler Other Motor Neuron Disord., 1, pp.293~299 (2000)
7. The Amyotrophic Lateral Sclerosis Functional Rating Scale, "Assessment of activities of daily living in patients with amyotrophic lateral sclerosis", Arch Neurol., 53, pp.141~147 (1996), The ALSCNTF treatment study (ACTS) phase I-II Study Group
8. de Carvalho M, "Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements", Amyotrophic Lateral Scler Other Motor Neuron Disord., 6, pp.202~212 (2005)
9. Cedarbaum JM, "The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function", J Neurol Sci., 169, pp.13~21 (1999), BDNF ALS Study Group (Phase III).
10. Mendell JR, "Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy", N Engl J Med., 320, pp.1592~1597 (1989)
11. Mitsumoto H, "Amyotrophic lateral sclerosis", pp.3~33 (1998), F. A. Davis Company
12. Lee KW, "Textbookof Neurology" (2005), EPUBLIC
13. Norris F, "Onset, natural history and outcome in idiopathic adult motor neuron disease", J Neurol Sci., 118, pp.48~55 (1993)
14. Neudert C, "The course of the terminal phase in patients with amyotrophic lateral sclerosis", J Neurol., 248, pp.612~616 (2001)
15. Forbes RB, "Unexpected decline in survival from amyotrophic lateral sclerosis", motor neuron disease, 2004, pp.75, 1753~1755
16. del Aguila MA, "Prognosis in amyotrophic lateral sclerosis: a populationbased study", Neurology, 60, pp.813~819 (2003)
17. Gubbay SS, "Amytorophic lateral sclerosis. A study of its presentation and prognosis", J Neuro.l, 232, pp.295~300 (1985)
18. Rosen AD, "Amyotrophic lateral sclerosis: clinical features and prognosis", Arch Neurol(Chicago)., 35, pp.638~642 (1978)
19. Annegers JF, "Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988", Arch Neurol, 48(6), pp.589~593 (1991)
20. Brooks BR, "What are the implications of early diagnosis? Maintaining optimal health as long as possible", Neurology., 53, pp.S43~S45 (1999)
21. Millul A, "Survival of patients with amyotrophic lateral sclerosis in a populationbased registry", Neuroepidemiology, 25, pp.114~119 (2005)
22. Park SH, "A Clinical Study on Amyotrophic Lateral Sclerosis", J Korean Neurol Assoc., 4(2), pp.200~208 (1986)
23. Jessica Mandrioli, "Amyotrophic lateral sclerosis: Prognostic indicators of survival", Amyotrophic Lateral Sclerosis, 7(4), pp.217~226 (2006)
24. Louwerse ES, "Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium", J Neurol Sci., 152, pp.10~17 (1997)
25. Rosen DR, "Mutations in Cu", Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, 1993, pp.362, 59~62
26. Weiss JH, "The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity", Science, 247, pp.1474~1477 (1990)
27. Drachman DB, "Amyotrophic lateral sclerosis: an unconventional autoimmune disease?", Ann Neurol., 26, pp.269~274 (1989)
28. Kim SH, "Effects of the Immunoglobulins of Amyotrophic Lateral Sclerosis on Intracellular Calcium in PC12 Cells", J Korean Neurol Assoc., 18(6), pp.728~734 (2000)
29. Chio A, "Early symptoms progression rate is related to ALS outcome. A prospective population-based study", Neurology, 59, pp.99~103 (2002)
30. Turner MR, "Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis", ALS and other motor neuron disorders, 3, pp.15~21 (2002)
31. Zoccolella S, "Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy", European Journal of Neurology, 14(3), pp.262~268 (2007)
32. Quality Standards Subcommittee of the American Academy of Neurology, "Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole", Neurology, 49, pp.657~659 (1997)
33. 최영숙, "아밀로이드베타단백(Aβ1-42)투여 후 마우스 소교세포의 활성산소종 생성과 보체조절유전자의 발현 및 탐식", 대한신경과학회지, 23(1), pp.88~95 (2005), 대한신경과학회
34. Kimura F, "Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS", Neurology, 66, pp.265~267 (2006)
35. 김현영, "한글판 Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised : 신뢰도와 타당도에 관한 예비연구", 대한신경과학회지, 25(2), pp.149~154 (2007), 대한신경과학회
36. Aitkens S, "Relationship of manual muscle testing to objective strength measurements", Muscle Nerve, 12(3), pp.173~177 (1989)
37. Medical Research Council, "Aids to the Examination of the Peripheral Nervous System", pp.1~2 (1976), HMSO
38. Kim DH, "Illustrations Kyokam Sa-am Do-in Acupucture", pp.475~480 (2002), Sogang
39. Yun-TaoMa, "Biomedical Acupuncture for Pain Management", pp.12~13 (2005), Churchill Livingstone
40. Jeremy Ross, "Acupuncture Point Combinations", pp.75~99 (2004), Churchill Livingstone

관련 논문AI추천